Company: AEMD
Filing Date: 2025-09-05
Form Type: 424B4
Source: 0001683168-25-006701
Chunk: 43

Company: AETHLON MEDICAL INC
Filing Date: 2025-09-05
Form: 424B4
Chunk 43
---
 discretion in the allocation of the net proceeds.

| 27 |

<div align='center'>SELLING SECURITYHOLDERS</div>

This prospectus covers the resale
or other disposition by the Selling Securityholders identified in the table below of up to 1,550,000 shares of common stock issuable
upon the exercise Inducement Warrants.

We are registering the shares
of common stock underlying the Inducement Warrants in order to permit the Selling Securityholders to offer the shares of common stock
for resale from time to time. The registration of such common stock does not necessarily mean, however, that any of the shares of common
stock will be offered or sold by the Selling Securityholders. We will not receive any proceeds from the sale of the common stock by the
Selling Securityholders, and we have borne and will continue to bear the costs relating to the registration of these shares of common
stock, other than commissions and discounts of agents or broker-dealers and transfer taxes, if any.

The Inducement Warrants held
by the Selling Securityholders contain limitations which prevent the holder from exercising those Inducement Warrants if such exercise
or conversion would cause the Selling Securityholders, together with certain related parties, to beneficially own a number of shares
of common stock which would exceed 4.99% of our then outstanding common stock following such exercise or conversion, excluding for purposes
of such determination, common stock issuable upon exercise of the Inducement Warrants which have not been exercised.

The table below sets forth,
as of August 21, 2025, the following information regarding the Selling Securityholders:

| · | the name of the Selling                                                                                                                    
 Securityholders;                                                                                                                           |
| · | the number of shares of                                                                                                                    
 common stock owned by the Selling Securityholders prior to this offering, without regard to any beneficial ownership limitations           
 contained in the Inducement Warrants;                                                                                                      |
| · | the number of shares of                                                                                                                    
 common stock to be offered by the Selling Securityholders in this offering;                                                                |
| · | the number of shares of                                                                                                                    
 common stock to be owned by the Selling Securityholders assuming the sale of all of the shares of common stock covered by this prospectus; 
 and                                                                                                                                        |
| · | the percentage of our issued                                                                                                               
 and outstanding shares of common stock to be owned by the Selling Securityholders assuming the sale of all of the common stock covered     
 by this prospectus based on the number of